It has been shown that reduced numbers of CD4+ and CD8+ T cells in patients admitted to the intensive care correlated with COVID-19-associated severity and mortality, suggesting that T cells are important for a favorable clinical outcome15,16. The gene discussed is CD4; the disease is COVID-19.